Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

GlaxoSmithKline provided financial support in the production of this content.

Reconsidering community pharmacy’s role in cold and flu

Outlining the vital role of each member of the pharmacy team and highlighting best practice when patients present with cold and flu ensures a consistent, high standard of care is available across pharmacy.

cold and flu foldout

Source: Julie Lee / The Pharmaceutical Journal

Each year, during cold and flu season (October to March), many patients consider phar­macy as the first port of call when feeling unwell from symptoms of cold and flu. The Pharmaceutical Journal conducted a survey of community pharmacists in April to May 2019, and 34% of respondents (n=371) reported that 6–10 patients present to community pharmacies every day seeking advice about cold and flu or to purchase an over-the-counter (OTC) product to help relieve their symptoms[1].

With tens of thousands of cold and flu consultations taking place each day, it is not surprising that there is wide variation in practice across the sector[1]. This results in subsequent differences in patient experience and inconsistent expectations of community pharmacy.

A 2017 Ipsos MORI survey asked more than 1,700 people aged 15 years and over what they would do if they had a respira­tory tract infection. Just 34% would consider an OTC medicine, and only 11% would approach the pharmacy for advice. For those patients who said they would go to a GP, NHS walk-in centre or out of hours healthcare service, just under 40% of patients said that they would expect to be given an antibiotic[2].

With many patients expecting to receive an antibiotic for a respira­tory tract infection, it is necessary for pharmacy teams to consider their role in antimicrobial stewardship (AMS) in the context of cold and flu. This role goes beyond simply challenging inappropriate prescribing of antimicrobials; it must include reshaping patient’s perceptions around cold and flu management[3]. Pharmacists must encourage their teams to reinforce public health messaging around prevention of infection and self-care for cold and flu, and they must strongly discourage patients from automatically seeking antibiotics. To have a positive impact on antimicrobial resistance rates, this change needs to begin at the start of the patient journey — at first presentation.

Although cold and flu are common conditions, their associated complications can be serious or fatal. Even with widespread uptake of the flu vaccine[4], there are an average of 600 flu-related deaths in the UK each year[5].

It is vital that consistent messaging around self-care is delivered by pharmacy teams in order to promote community pharmacy as an accessible point of care and the first port of call for minor conditions.

Aimi Dickinson, pharmacist professional support manager at Boots, and Olutayo Arikawe, superintendent pharmacist at Priory Pharmacy, discuss the current cold and flu management landscape and how pharmacy can do better to achieve best practice

Pharmacy’s role in the self-care agenda

Conditions that can be self-managed result in an estimated 57 million GP consultations and 3.7 million visits to accident and emergency (A&E) each year, costing the NHS £2.3bn[6],[7].

With increasing numbers of consultations and difficulty fulfilling the demands and expectations of patients, there is a drive to shift more care from hospitals to the community. As a result, people are finding it increasingly difficult to get GP appointments and waiting times are increasing[8].

A survey of 5,011 UK adults aged 18–75 years, conducted by Self Care Nation in 2016, found that most people are aware of the impact that their use of NHS services has. Yet more than one third of survey respondents visited a GP for a minor condition they could have treated either themselves, or with advice from a pharmacist[9]. In addition, 92% of respondents felt that it is important to take responsibility for their own health to ease the burden on the NHS, but only 29% visited a pharmacy more than once a month, usually to collect a repeat prescription[9].

Since 2016, several campaigns have aimed to raise awareness of the expertise of pharmacists and their teams among the public[10]. There is now a shift towards self-care and an emphasis on promoting the appropriate use of antibiotics and how it supports the AMS role of community pharmacists and their teams.

The development of primary care networks, as well as increases in NHS 111 referrals to community pharmacy through the NHS Urgent Medicine Supply Advanced Supply Service and the Digital Minor Illness Service, could provide the momentum for community pharmacy to engage with patients about self-care. It may also give community pharmacy the opportunity to demonstrate how it can support patients to manage acute minor illness[11].

Involving the patient in decision making

As self-care will be essential to future management of cold and flu, any decisions should be made in collaboration with the patient, taking into consideration their priorities and lifestyle. It is necessary that patients are advised about symptom duration and that they are aware of what actions to take should their symptoms worsen or not improve within the discussed timeframe[1]. Pharmacological and non-phar­macological options for self-care should be outlined alongside the red flag symptoms that would require re-presentation or referral.

As patients will be engaged and empowered in decision making about their own care, it provides an opportunity for community pharmacy to discuss AMS. To do this, pharmacists and pharmacy teams need to understand the link between effective management of patients with cold and flu symptoms and effective AMS. The training materials produced in the subsequent parts of this campaign will help bridge the gap between the pharmacy team and patients to help ensure that a consistent level of care is provided across the sector. This will be achieved by outlining how the pharmacy team should approach cold and flu consultations, whether patients present seeking advice or after self-selecting a product. There is an emphasis on aligning the sector with other public health messaging related to the AMS role of pharmacy (e.g. infection control and discouraging inappropriate prescribing and requests for antibiotics).

Moving forward

Now is the time to challenge existing behaviours within community pharmacy and to view self-care, infection prevention and sympto­matic relief in the management of cold and flu symptoms in the context of AMS. This will ensure a consistent standard of patient care for cold and flu consultations across the sector.

As medicines experts, community phar­macists must recognise the importance of updating their knowledge and to upskill their team as needed, focusing on the quality, rather than the quantity, of training.

Using a ‘train the trainer’ approach, The Pharmaceutical Journal has developed a content package as part of the cold and flu partnership with GSK, which aims to help pharmacists working across multiple and independent community pharmacies to implement a consistent approach and standard of care for consultations with patients presenting to ask advice on how to manage cold and flu symptoms, or after having selected an OTC product.

The training materials will come in three parts and will be published at the beginning of October 2019:  

Part one

  • An overview of consultation skills, techniques and frameworks.

Part two

  • Consultation approaches for cold and flu;
  • Defining the roles and responsibilities of each member of the team;
  • Focus on practical skills development.

Part three

  • Detailed training approaches for the whole team;
  • How to implement a training programme and the new standard within your pharmacy. 

Citation: The Pharmaceutical Journal, September 2019, online. doi: 10.1211/PJ.2019.20206985

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Statistics

    Pharmaceutical Statistics

    This book on basic statistics has been specifically written for pharmacy students.

    £33.00Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.